Type 2 Diabetes Mellitus: New Approaches to Optimize Medical Care in General Practice
DIANA
DIANA - Diabetes Mellitus: Neue Wege Der Optimierung Der allgemeinärztlichen Betreuung
1 other identifier
interventional
204
1 country
37
Brief Summary
Patients with type-2 diabetes mellitus have an higher risk developing secondary disorders. In an epidemiological longitudinal study of about 1.150 patients with type 2 diabetes mellitus we investigate determinants and predictors for long-term prognosis. The patients are recruited and supervised in practices of general practitioners of the administrative district of Ludwigsburg/Heilbronn (Baden-Württemberg, Germany). In a subgroup of about 200 patients with a dissatisfactory metabolic status (HbA1c \> 7,5%) a randomised interventional study is performed. The intervention comprises a telephone counseling by the medical secretary of each practice executed in a predefined period of time. The outcome parameters of interest are the change of HbA1c, the development of secondary disorders and adverse events, quality of life and risk factor control, as well as hospitalization and mortality. The aim of the study was to develop an patient-centred instrument implementable in the routine medical care in order to enhance the prognosis of patients with type-2 diabetes mellitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes-mellitus
Started Oct 2008
Longer than P75 for not_applicable type-2-diabetes-mellitus
37 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2008
CompletedFirst Posted
Study publicly available on registry
August 27, 2008
CompletedStudy Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedDecember 11, 2013
December 1, 2013
3.8 years
August 26, 2008
December 10, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HbA1c
18 months
Secondary Outcomes (6)
hospitalization
18 month
CHD, mortality
18 months
lipid metabolism control
18 months
risk factor control (eg. body weight, physical activity, smoking)
18 months
health-related quality of life
18 months
- +1 more secondary outcomes
Study Arms (2)
Control group
NO INTERVENTIONNo telephone counseling + usual care
Telephone Counseling
EXPERIMENTALTelephone counseling + usual care
Interventions
Telephone counseling is provided once a month by the medical secretary of the general practitioner's practices
Eligibility Criteria
You may qualify if:
- Patient with type-2 diabetes mellitus attending the general practitioner's in the time from October to December 2008
- Ability to take part in the study
You may not qualify if:
- Nursing home resident
- Insufficient knowledge of the German language
- Palliative health care with limited life expectancy
- Emergency outpatient
- All outpatients who attend the general practitioner by way of exception
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- German Cancer Research Centerlead
- Heidelberg Universitycollaborator
- German Federal Ministry of Education and Researchcollaborator
Study Sites (37)
Christoph Lücke, MD
Beilstein, Baden-Wurttemberg, 71717, Germany
Andrea Walliser-Klöpfer, MD
Benningen am Neckar, Baden-Wurttemberg, 71724, Germany
Nader Heydari, MD
Fellbach, Baden-Wurttemberg, 70737, Germany
Adelheid Halttunen, MD
Gemmingen, Baden-Wurttemberg, 75050, Germany
Hans-Joachim Essich, MD
Heilbronn, Baden-Wurttemberg, 74072, Germany
Jürgen Wollweber, MD
Heilbronn, Baden-Wurttemberg, 74072, Germany
Volker Naser, MD
Heilbronn, Baden-Wurttemberg, 74076, Germany
Andreas Wößner, MD
Heilbronn, Baden-Wurttemberg, 74078, Germany
Ullrich Barthelmes, MD
Heilbronn, Baden-Wurttemberg, 74080, Germany
Axel Möller, MD
Heilbronn, Baden-Wurttemberg, 74081, Germany
Miroslaw Wyszynski, MD
Heilbronn, Baden-Wurttemberg, 74081, Germany
Ulrich Hofmann, MD
Ilsfeld-Auenstein, Baden-Wurttemberg, 74360, Germany
Hans Martin Schweizer, MD
Korntal, Baden-Wurttemberg, 70825, Germany
Eberhard Rieker, MD
Lauffen am Neckar, Baden-Wurttemberg, 74348, Germany
Bernd Leuchs, MD
Leonberg, Baden-Wurttemberg, 71229, Germany
Gerhard Günther, MD
Leonberg, Baden-Wurttemberg, 71229, Germany
Thomas Baartz, MD
Leonberg, Baden-Wurttemberg, 71229, Germany
Monika Muhler, MD
Löwenstein, Baden-Wurttemberg, 74245, Germany
Ulrich Wagner, MD
Ludwigsburg, Baden-Wurttemberg, 71634, Germany
Martin Heinrich, MD
Ludwigsburg, Baden-Wurttemberg, 71640, Germany
Franz Lang, MD
Marbach am Neckar, Baden-Wurttemberg, 71672, Germany
Jürgen Wirth, MD
Marbach am Neckar, Baden-Wurttemberg, 71672, Germany
Alfred Preisner, MD
Massenbachhausen, Baden-Wurttemberg, 74252, Germany
Michael Spiel, MD
Murr, Baden-Wurttemberg, 71711, Germany
Hans-Jürgen Sommerer, MD
Neckarsulm, Baden-Wurttemberg, 74081, Germany
Dietmar Kunz, MD
Neckarsulm, Baden-Wurttemberg, 74172, Germany
Hartmut Jungjohann, MD
Neckarsulm, Baden-Wurttemberg, 74172, Germany
Jürgen Herbers, MD
Pleidelsheim, Baden-Wurttemberg, 74385, Germany
Ulf-Michael Werner, MD
Remshalden, Baden-Wurttemberg, 73630, Germany
Frank Röder, MD
Schwaikheim, Baden-Wurttemberg, 71409, Germany
Gisela Gramlich, MD
Untergruppenbach, Baden-Wurttemberg, 74199, Germany
Ildiko Tasic
Vaihingen-Enz, Baden-Wurttemberg, 71665, Germany
Karl Schütz, MD
Weinsberg, Baden-Wurttemberg, 74189, Germany
Sigmund Jakob
Weinsberg, Baden-Wurttemberg, 74189, Germany
Kurt Weber, MD
Weissach, Baden-Wurttemberg, 71287, Germany
Dietmar Zinßer, MD
Winnenden, Baden-Wurttemberg, 71364, Germany
Odilo Schnabel, MD
Zaberfeld, Baden-Wurttemberg, 74374, Germany
Related Publications (2)
Mons U, Raum E, Kramer HU, Ruter G, Rothenbacher D, Rosemann T, Szecsenyi J, Brenner H. Effectiveness of a supportive telephone counseling intervention in type 2 diabetes patients: randomized controlled study. PLoS One. 2013 Oct 30;8(10):e77954. doi: 10.1371/journal.pone.0077954. eCollection 2013.
PMID: 24205043DERIVEDKramer HU, Raum E, Ruter G, Schottker B, Rothenbacher D, Rosemann T, Szecsenyi J, Brenner H. Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study. Cardiovasc Diabetol. 2012 Jul 27;11:88. doi: 10.1186/1475-2840-11-88.
PMID: 22838970DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hermann Brenner, MD, MPH
German Cancer Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2008
First Posted
August 27, 2008
Study Start
October 1, 2008
Primary Completion
July 1, 2012
Study Completion
December 1, 2012
Last Updated
December 11, 2013
Record last verified: 2013-12